 Home > Medical News > Latest Medical News > Amgen postpones the launch of Samsung's Enbrel biosimilar to 2029

Amgen postpones the launch of Samsung's Enbrel biosimilar to 2029

 Last Update: 2022-01-01
 Source: Internet
 Author: User

Tags

tumor markers list

treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

This summer, the US Supreme Court refused to accept Sandoz and Amgen's patent dispute over its anti-inflammatory blockbuster Enbrel

According to the latest verdict, the U.

The update of this court decision marks the second patent setback for Enbrel biosimilars this year

According to the latest judgment, Samsung Bioepis will not be able to manufacture, sell or import Enbrel biosimilar drugs in the United States before 2029

Enbrel is the world's first TNF inhibitor used in rheumatoid arthritis and ankylosing spondylitis.

In terms of patents for other therapies, Amgen also recently requested the US Supreme Court to intervene and review its long-standing PCSK9 patent dispute with Sanofi and Regeneron

Reference source: Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.